Top Markets
Coin of the day
Zymeworks Inc. Zymeworks Inc.

Zymeworks Inc.

ZYME
Clasificación en acciones #6243
Zymeworks Inc. is a biopharmaceutical firm in the clinical development phase,... Zymeworks Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to identifying, advancing, and bringing to market biological therapies aimed at combating cancer. Its pipeline features two primary experimental treatments: zanidatamab, a cutting-edge bispecific antibody currently undergoing Phase 1 and Phase 2 studies for various malignancies such as those affecting the biliary tract, gastroesophageal region (adenocarcinomas), breast, and colon; and ZW49, an antibody-drug conjugate targeting two sites on the human epidermal growth factor receptor 2 (HER2), which is in Phase 1 trials for advanced or spreading tumors that express HER2. Zymeworks maintains significant alliances with several pharmaceutical leaders, including Merck Sharp & Dohme Research Ltd., Eli Lilly and Company, Bristol-Myers Squibb company, GlaxoSmithKline Intellectual Property Development Ltd., Daiichi Sankyo Co., Ltd., Janssen Biotech, Inc., BeiGene, Ltd., and Exelixis, Inc. Furthermore, it engages in cooperative research and licensing agreements with LEO Pharma A/S, specifically for the exploration, advancement, and market introduction of bispecific antibodies, and with Iconic Therapeutics, Inc. Established in 2003, Zymeworks Inc. operates from its headquarters located in Vancouver, Canada.
Precio por acción
$29.15
Capitalización bursátil
$2.14B
Cambio (1 día)
-0.53%
Cambio (1 año)
95.24%
País
US
Comercio Zymeworks Inc. (ZYME)

Categoría

Historial del precio de la acción de Zymeworks Inc. (ZYME)
Precio más alto de cierre: $26.22 el 2026-08-01

Precio más bajo de cierre: $13.00 el 2017-04-01
Historial del precio de la acción de Zymeworks Inc. desde 2017 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -12.16%
2025 90.41%
2024 44.87%
2023 30.92%
2022 -56.92%
2021 -67.45%
2020 19.67%
2019 233.57%
2018 63.85%
2017 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$548.36 40.94%
US
$1.06K 49.46%
NL
$122.63 -12.65%
AU
$140.81 461.00%
US
$765.25 7.19%
CH